Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs031250402) titled 'Inhibitory Effect of Anamorelin on the Decrease of Body Weight in Patients with Idiopathic Pleuroparenchymal Fibroelastosis Awaiting Lung Transplantation' on Oct. 1.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), historical control, single assignment, treatment purpose
Primary Sponsor: Sato Masaaki
Condition:
idiopathic pleuroparenchymal fibroelastosis (IPPFE)
Intervention:
Off-label use of anamorelin for patients with IPPFE (Idiopathic Pleuroparenchymal Fibroelastosis)
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 01/10/2025
Target Sample S...